Integra Lifesciences Holdings Corp (IART)

45.81
NASDAQ : Health Care
Prev Close 45.81
Day Low/High 0.00 / 0.00
52 Wk Low/High 33.50 / 45.87
Avg Volume 649.40K
Exchange NASDAQ
Shares Outstanding 75.26M
Market Cap 3.29B
EPS 1.00
P/E Ratio 46.53
Div & Yield N.A. (N.A)

Latest News

Integra LifeSciences Announces Expansion Of Credit Facility To Include New $700 Million Term Loan

Integra LifeSciences Announces Expansion Of Credit Facility To Include New $700 Million Term Loan

Financing now secured for the planned acquisition of Codman Neurosurgery

Dr. Reddy's And Integra LifeSciences Enter Into An Agreement To Market And Distribute DuraGen Plus® And Suturable DuraGen® Dural Regeneration In India

Dr. Reddy's And Integra LifeSciences Enter Into An Agreement To Market And Distribute DuraGen Plus® And Suturable DuraGen® Dural Regeneration In India

Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that they have entered into an...

Integra LifeSciences Reports Fourth Quarter And Full-Year 2016 Financial Results And Updates 2017 Full-Year Guidance

Integra LifeSciences Reports Fourth Quarter And Full-Year 2016 Financial Results And Updates 2017 Full-Year Guidance

2016 Results and 2017 Guidance in line with January 10, 2017 Preliminary Announcement

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra hopes this deal will grow its revenue to $2 billion sooner than expected.

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

The company hopes the JNJ assets will give revenue growth a boost.

Derma Sciences Soars Almost 40% on Buyout by Integra

Derma Sciences Soars Almost 40% on Buyout by Integra

The company's shares hit $6.95 Wednesday midday.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DLR, ESXB, IART, NMR, PBIB, PLNT, SANW, TCK Downgrades: AAN, ABMD, AXTA, CMC, CMPR, CVI, CVRR, DSPG, EHTH, ESSA, FCFS, NPTN, NWS, UHT, VDSI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Analysts' Actions -- AES, CBOE, Las Vegas Sands, PacWest Bancorp and More

Analysts' Actions -- AES, CBOE, Las Vegas Sands, PacWest Bancorp and More

Here are Tuesday's top research calls, including upgrades for CBOE and Las Vegas Sands, and downgrades for AES and PacWest Bancorp.

TheStreet Quant Rating: A- (Buy)